Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfeeder.co
AZ - Early R&D
Get the latest updates from AZ - Early R&D directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 1 hour ago
Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD ...
1 day ago
... SMARCA2 inhibitor FHD-909 showing complete and durable tumor regression together with...
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
1 day ago
Conditions: PDAC; PDAC - Pancreatic Ductal Adenocarcinoma; NSCLC; RAS Mutation; MTAP Deletion...
A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors
1 day ago
Conditions: MTAP-null Non-Small-Cell Lung Cancer; MTAP-null Solid Tumors Interventions: Drug: Anvumetostat; Drug...
Foghorn Therapeutics presents new preclinical data on SMARCA2 inhibitor FHD-909 and ...
1 day ago
Foghorn Therapeutics has released new preclinical data for its selective SMARCA2 inhibitor...
Foghorn AACR data show tumor regression in mice | FHTX Stock News
1 day ago
SMARCA2 is a human gene that makes a protein acting like a...
Foghorn details new AACR preclinical data and pipeline | FHTX 8-K Filing - Stock Titan
1 day ago
The company highlighted FHD-909, a selective SMARCA2 inhibitor partnered with Lilly, which...
CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer
2 days ago
Conditions: Advanced Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8...
Robotic Gait Rehabilitation in Parkinson's Disease
2 days ago
Conditions: Parkinson Disease; Gait Disorder, Sensorimotor Interventions: Device: G-EO End-Effector Gait Trainer...
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
2 days ago
Conditions: Locally Advanced Solid Tumor Interventions: Drug: TNG462; Drug: Pembrolizumab Sponsors: Tango...
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
2 days ago
Conditions: Lymphoma; Non-Hodgkin Lymphoma; Hodgkin Lymphoma; Peripheral T-cell Lymphoma (PTCL); PTCL-NOS; ALCL...
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
8 days ago
Conditions: Lung Non-Small Cell Carcinoma; Stage IIIB Lung Cancer AJCC v8; Stage...
Testing the Addition of an Anti-cancer Drug, SNDX-5613, to the Standard Chemotherapy Treatment (Daunorubicin and Cytarabine) for Newly Diagnosed Patients With Acute Myeloid Leukemia That Has Changes in NPM1 or MLL/KMT2A Gene
8 days ago
Conditions: Acute Myeloid Leukemia With KMT2A Rearrangement; Acute Myeloid Leukemia With NPM1...